| Modification and validation of the Birmingham Vasculitis Activity Score (version 3) C Mukhtyar, R Lee, D Brown, D Carruthers, B Dasgupta, S Dubey, ... Annals of the rheumatic diseases 68 (12), 1827-1832, 2009 | 1145 | 2009 |
| The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies F Rees, M Doherty, MJ Grainge, P Lanyon, W Zhang Rheumatology 56 (11), 1945-1961, 2017 | 774 | 2017 |
| The incidence and prevalence of systemic lupus erythematosus in the UK, 1999–2012 F Rees, M Doherty, M Grainge, G Davenport, P Lanyon, W Zhang Annals of the rheumatic diseases 75 (1), 136-141, 2016 | 361 | 2016 |
| 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis JC Robson, PC Grayson, C Ponte, R Suppiah, A Craven, A Judge, ... Arthritis & Rheumatology 74 (3), 393-399, 2022 | 286 | 2022 |
| 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis PC Grayson, C Ponte, R Suppiah, JC Robson, A Craven, A Judge, ... Arthritis & Rheumatology 74 (3), 386-392, 2022 | 285 | 2022 |
| Randomized controlled trial of rituximab and cost‐effectiveness analysis in treating fatigue and oral dryness in primary Sjögren's syndrome SJ Bowman, CC Everett, JL O'Dwyer, P Emery, C Pitzalis, WF Ng, ... Arthritis & Rheumatology 69 (7), 1440-1450, 2017 | 271 | 2017 |
| Radiographic assessment of symptomatic knee osteoarthritis in the community: definitions and normal joint space P Lanyon, S O’Reilly, A Jones, M Doherty Annals of the rheumatic diseases 57 (10), 595-601, 1998 | 265 | 1998 |
| British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis SL Mackie, C Dejaco, S Appenzeller, D Camellino, C Duftner, ... Rheumatology 59 (3), e1-e23, 2020 | 237 | 2020 |
| Assessment of a genetic contribution to osteoarthritis of the hip: sibling study P Lanyon, K Muir, S Doherty, M Doherty Bmj 321 (7270), 1179-1183, 2000 | 225 | 2000 |
| Infliximab in the treatment of refractory posterior uveitis A Joseph, D Raj, HS Dua, PT Powell, PC Lanyon, RJ Powell Ophthalmology 110 (7), 1449-1453, 2003 | 224 | 2003 |
| Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial RB Jones, TF Hiemstra, J Ballarin, DE Blockmans, P Brogan, A Bruchfeld, ... Annals of the rheumatic diseases 78 (3), 399-405, 2019 | 216 | 2019 |
| 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis R Suppiah, JC Robson, PC Grayson, C Ponte, A Craven, S Khalid, ... Arthritis & Rheumatology 74 (3), 400-406, 2022 | 214 | 2022 |
| Prevalence, risk factors and associations of primary Raynaud's phenomenon: systematic review and meta-analysis of observational studies R Garner, R Kumari, P Lanyon, M Doherty, W Zhang BMJ open 5 (3), e006389, 2015 | 180 | 2015 |
| Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double‐blind, placebo‐controlled trial of the angiotensin … AE Gliddon, CJ Doré, CM Black, N McHugh, R Moots, CP Denton, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2007 | 151 | 2007 |
| Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS) AL Herrick, X Pan, S Peytrignet, M Lunt, R Hesselstrand, L Mouthon, ... Annals of the rheumatic diseases 76 (7), 1207-1218, 2017 | 144 | 2017 |
| Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis RM Smith, RB Jones, U Specks, S Bond, M Nodale, R Aljayyousi, ... Annals of the rheumatic diseases 79 (9), 1243-1249, 2020 | 136 | 2020 |
| Development of a logically devised line drawing atlas for grading of knee osteoarthritis Y Nagaosa, M Mateus, B Hassan, P Lanyon, M Doherty Annals of the rheumatic diseases 59 (8), 587-595, 2000 | 131 | 2000 |
| Health-related utility values of patients with primary Sjögren's syndrome and its predictors D Lendrem, S Mitchell, P McMeekin, S Bowman, E Price, CT Pease, ... Annals of the rheumatic diseases 73 (7), 1362-1368, 2014 | 126 | 2014 |
| Risk factors for clinical coronary heart disease in systemic lupus erythematosus: the lupus and atherosclerosis evaluation of risk (LASER) study S Haque, C Gordon, D Isenberg, A Rahman, P Lanyon, A Bell, P Emery, ... The Journal of rheumatology 37 (2), 322-329, 2010 | 118 | 2010 |
| Effect of rituximab on a salivary gland ultrasound score in primary Sjögren’s syndrome: results of the TRACTISS randomised double-blind multicentre substudy BA Fisher, CC Everett, J Rout, JL O’Dwyer, P Emery, C Pitzalis, WF Ng, ... Annals of the rheumatic diseases 77 (3), 412-416, 2018 | 112 | 2018 |
